Abstract

Protecting Health Care Workers (HCWs) during routine care of suspected or confirmed COVID-19 patients is of paramount importance to halt the SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2) pandemic. The WHO, ECDC and CDC have issued conflicting guidelines on the use of respiratory filters (N95) by HCWs. We searched PubMed, Embase and The Cochrane Library from the inception to March 21, 2020 to identify randomized controlled trials (RCTs) comparing N95 respirators versus surgical masks for prevention of COVID-19 or any other respiratory infection among HCWs. The grading of recommendations, assessment, development, and evaluation (GRADE) was used to evaluate the quality of evidence. Four RCTs involving 8736 HCWs were included. We did not find any trial specifically on prevention of COVID-19. However, wearing N95 respirators can prevent 73 more (95% CI 46–91) clinical respiratory infections per 1000 HCWs compared to surgical masks (2 RCTs; 2594 patients; low quality of evidence). A protective effect of N95 respirators in laboratory-confirmed bacterial colonization (RR = 0.41; 95%CI 0.28–0.61) was also found. A trend in favour of N95 respirators was observed in preventing laboratory-confirmed respiratory viral infections, laboratory-confirmed respiratory infection, and influenza like illness. We found no direct high quality evidence on whether N95 respirators are better than surgical masks for HCWs protection from SARS-CoV-2. However, low quality evidence suggests that N95 respirators protect HCWs from clinical respiratory infections. This finding should be contemplated to decide the best strategy to support the resilience of healthcare systems facing the potentially catastrophic SARS-CoV-2 pandemic.

Highlights

  • The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) outbreak emerged in China in December 2019 and it was recognised as a pandemic by the World Health Organization (WHO) on 11 March [1]

  • Results of Risk of bias assessment) we show the risk of bias of included studies: Loeb et al 2009 [37] was judged at low risk of bias, the remaining [5, 38,39,40] were assessed for additional bias related to clustering of which two out of three cluster randomized controlled trials (RCTs) were assessed as high risk of bias for imbalance at baseline

  • This is the first systematic review on the efficacy of N95 respirators versus surgical masks among healthcare workers (HCWs) accounting for possible bias derived from cluster trials and evaluating the findings from a public health policy perspective

Read more

Summary

Introduction

The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) outbreak emerged in China in December 2019 and it was recognised as a pandemic by the World Health Organization (WHO) on 11 March [1]. Claims of insufficient protection of HCWs by personal protective equipment, in particular with regards to the use of surgical masks, have fuelled the scientific and social media debate in several countries. The direct evidence supporting the WHO guidelines is based on very few case reports on the absence of SARS-CoV-2 in air samples taken in highly protected environments where a rapid dilution of aerosols occurs, the absence of infection of HCWs exposed for a limited time or limited viral loads, or on modelling of epidemiologic patterns of transmission [9,10,11,12]. The airborne (aerosol) opportunistic route of transmission has been documented for SARS and MERS caused by closely related coronaviruses responsible of severe nosocomial infections among HCWs. Aerosol filtering respirators were recommended for SARS during 2002–03 outbreak [13]. None of the above mentioned guidelines adopted the suggested Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for directing public health policy decisions and they did not explicitly consider the potentially catastrophic consequences of deferring the recommendation of N95 respirators for HCWs while awaiting more robust evidence

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call